Evidence supporting the use of: Vitamin E (tocopheryl acetate)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (tocopheryl acetate) has been investigated for its potential role in the treatment and support of dementia, particularly Alzheimer's disease, due to its antioxidant properties. Oxidative stress is believed to play a role in the pathogenesis of neurodegenerative diseases, and Vitamin E, as a lipid-soluble antioxidant, was hypothesized to help mitigate neuronal damage. Several clinical trials have assessed the efficacy of Vitamin E supplementation in slowing cognitive decline. The most notable is the 1997 study by Sano et al. in the New England Journal of Medicine, which found that high-dose Vitamin E (2,000 IU/day) modestly delayed the progression of Alzheimer's disease in patients with moderate severity. However, subsequent studies have yielded mixed results, with some failing to demonstrate significant cognitive benefits, and concerns have arisen about the safety of high doses (potential increased mortality risk). Systematic reviews and meta-analyses generally conclude that there is limited and inconsistent evidence to support Vitamin E supplementation as a treatment for dementia. Thus, while there is some scientific basis and clinical investigation, the overall strength of evidence is low, and Vitamin E is not widely recommended as a primary therapy for dementia in clinical guidelines.

More about Vitamin E (tocopheryl acetate)
More about Dementia

Products containing Vitamin E (tocopheryl acetate)

We currently have no products on Vitabase that contain this ingredient.